Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04686305
Brief Title: Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC (DL03)

First Submitted : December 8, 2020
First Submitted that Met QC Criteria : December 22, 2020
First Posted : December 28, 2020

Last Update Submitted that Met QC Criteria : September 10, 2021
Last Update Posted : September 16, 2021